C4 Therapeutics, Inc.CCCCNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank57
3Y CAGR-4.0%
5Y CAGR+5.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-4.0%/yr
vs +42.5%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
-46.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
2025$104.24M-5.8%
2024$110.64M-6.0%
2023$117.71M-0.1%
2022$117.84M+24.5%
2021$94.67M+20.7%
2020$78.44M+63.2%
2019$48.06M+68.1%
2018$28.59M-